As of Feb 11
| +0.01 / +0.60%|
The 3 analysts offering 12-month price forecasts for Sequenom Inc have a median target of 1.50, with a high estimate of 2.40 and a low estimate of 0.90. The median estimate represents a -10.18% decrease from the last price of 1.67.
The current consensus among 4 polled investment analysts is to Hold stock in Sequenom Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.